Pharma Pulse: US-UK Trade Deal Forces Pricing Shift, as Lilly Deepens GLP-1 Price Cuts and RSV-Asthma Link Confirmed

Dec 02, 10:30 AM

Headliner
Share
Subscribe
In today’s Pharma Pulse, a US-UK trade agreement mandates that the UK’s NICE agency raises its QALY threshold, increasing access to innovative drugs, and much more. 
Share
Subscribe
Next
Pharma Pulse: Long COVID Exercise Win, $150M Gene Editing Play, and Compounding Pharmacy Expansions
Top episodes
Incorporating AI into Commercialization Plans
by Pharmaceutical Commerce
Overcoming Supply Chain Challenges
by Pharmaceutical Commerce
The Capabilities of a 3PL Provider
by Pharmaceutical Commerce